Compass Therapeutics (CMPX) EBIT Growth (3y) (2021 - 2026)
Compass Therapeutics (CMPX) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Compass Therapeutics |
379.32 Mn |
184.64 Mn |
- |
-27.86% |
| Date | Value |
|---|
| Mar 31, 2026 |
-27.86% |
| Dec 31, 2025 |
-11.76% |
| Sep 30, 2025 |
-7.88% |
| Jun 30, 2025 |
-32.84% |
| Mar 31, 2025 |
-35.75% |
| Dec 31, 2024 |
-8.43% |
| Sep 30, 2024 |
-27.87% |
| Mar 31, 2024 |
-20.28% |
| Sep 30, 2023 |
-10.00% |
| Jun 30, 2023 |
-38.04% |
| Mar 31, 2023 |
-18.53% |
| Dec 31, 2022 |
-979.75% |
| Sep 30, 2022 |
-14.54% |
| Jun 30, 2022 |
-1.19% |
| Dec 31, 2021 |
-1,019.47% |
| Sep 30, 2021 |
-809.35% |
